-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2024.
- Day One Biopharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 86.7 M shares, a 20.4% increase year-over-year.
- Day One Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 79.8 M shares, a 21.9% increase from 2022.
- Day One Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 65.5 M shares, a 77.1% increase from 2021.
- Day One Biopharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 37 M shares, a 568% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)